Praxis Home Retail Limited
Praxis Home Retail Limited (PRAXIS.NS) Stock Competitors & Peer Comparison
See (PRAXIS.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRAXIS.NS | ₹7.81 | +0.00% | 1.5B | 4.23 | ₹1.94 | N/A |
| ETERNAL.BO | ₹271.95 | +0.00% | 2.5T | 1120.63 | ₹0.24 | N/A |
| ZOMATO.NS | ₹215.19 | +0.00% | 2T | 286.92 | ₹0.75 | N/A |
| ZOMATO.BO | ₹215.25 | +0.00% | 2T | 377.63 | ₹0.57 | N/A |
| SWIGGY.NS | ₹326.65 | +0.00% | 840.7B | -17.39 | -₹18.62 | N/A |
| SWIGGY.BO | ₹326.65 | +0.00% | 840.1B | -17.75 | -₹18.23 | N/A |
| NYKAA.NS | ₹267.46 | +0.00% | 760.3B | 542.00 | ₹0.49 | N/A |
| NYKAA.BO | ₹267.40 | +0.00% | 759.2B | 541.22 | ₹0.49 | N/A |
| REDTAPE.NS | ₹125.15 | +0.00% | 69.6B | 32.80 | ₹3.84 | +0.60% |
| AVL.NS | ₹490.70 | -0.08% | 62.8B | 56.87 | ₹8.55 | +0.23% |
Stock Comparison
PRAXIS.NS vs ETERNAL.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ETERNAL.BO has a market cap of 2.5T. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ETERNAL.BO trades at ₹271.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ETERNAL.BO's P/E ratio is 1120.63. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ETERNAL.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ETERNAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ETERNAL.BO's competition here
PRAXIS.NS vs ZOMATO.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ZOMATO.NS has a market cap of 2T. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ZOMATO.NS trades at ₹215.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ZOMATO.NS's P/E ratio is 286.92. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ZOMATO.NS's ROE of +0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ZOMATO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ZOMATO.NS's competition here
PRAXIS.NS vs ZOMATO.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ZOMATO.BO has a market cap of 2T. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ZOMATO.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ZOMATO.BO's P/E ratio is 377.63. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ZOMATO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ZOMATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ZOMATO.BO's competition here
PRAXIS.NS vs SWIGGY.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, SWIGGY.NS has a market cap of 840.7B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while SWIGGY.NS trades at ₹326.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas SWIGGY.NS's P/E ratio is -17.39. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to SWIGGY.NS's ROE of -0.48%. Regarding short-term risk, PRAXIS.NS is more volatile compared to SWIGGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check SWIGGY.NS's competition here
PRAXIS.NS vs SWIGGY.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, SWIGGY.BO has a market cap of 840.1B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while SWIGGY.BO trades at ₹326.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas SWIGGY.BO's P/E ratio is -17.75. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to SWIGGY.BO's ROE of -0.48%. Regarding short-term risk, PRAXIS.NS is more volatile compared to SWIGGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check SWIGGY.BO's competition here
PRAXIS.NS vs NYKAA.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, NYKAA.NS has a market cap of 760.3B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while NYKAA.NS trades at ₹267.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas NYKAA.NS's P/E ratio is 542.00. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to NYKAA.NS's ROE of +0.11%. Regarding short-term risk, PRAXIS.NS is more volatile compared to NYKAA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check NYKAA.NS's competition here
PRAXIS.NS vs NYKAA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, NYKAA.BO has a market cap of 759.2B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while NYKAA.BO trades at ₹267.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas NYKAA.BO's P/E ratio is 541.22. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to NYKAA.BO's ROE of +0.11%. Regarding short-term risk, PRAXIS.NS is more volatile compared to NYKAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check NYKAA.BO's competition here
PRAXIS.NS vs REDTAPE.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, REDTAPE.NS has a market cap of 69.6B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while REDTAPE.NS trades at ₹125.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas REDTAPE.NS's P/E ratio is 32.80. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to REDTAPE.NS's ROE of +0.27%. Regarding short-term risk, PRAXIS.NS is more volatile compared to REDTAPE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check REDTAPE.NS's competition here
PRAXIS.NS vs AVL.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, AVL.NS has a market cap of 62.8B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while AVL.NS trades at ₹490.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas AVL.NS's P/E ratio is 56.87. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to AVL.NS's ROE of +0.19%. Regarding short-term risk, PRAXIS.NS is more volatile compared to AVL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check AVL.NS's competition here
PRAXIS.NS vs RTNINDIA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, RTNINDIA.BO has a market cap of 43B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while RTNINDIA.BO trades at ₹32.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas RTNINDIA.BO's P/E ratio is -10.45. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to RTNINDIA.BO's ROE of -0.38%. Regarding short-term risk, PRAXIS.NS is more volatile compared to RTNINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check RTNINDIA.BO's competition here
PRAXIS.NS vs EMIL.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, EMIL.BO has a market cap of 38.9B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while EMIL.BO trades at ₹99.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas EMIL.BO's P/E ratio is 41.58. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to EMIL.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS.NS is more volatile compared to EMIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check EMIL.BO's competition here
PRAXIS.NS vs EMIL.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, EMIL.NS has a market cap of 38.8B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while EMIL.NS trades at ₹99.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas EMIL.NS's P/E ratio is 41.55. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to EMIL.NS's ROE of +0.06%. Regarding short-term risk, PRAXIS.NS is more volatile compared to EMIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check EMIL.NS's competition here
PRAXIS.NS vs GARGI.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, GARGI.BO has a market cap of 9.4B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while GARGI.BO trades at ₹900.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas GARGI.BO's P/E ratio is 31.12. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to GARGI.BO's ROE of +0.29%. Regarding short-term risk, PRAXIS.NS is more volatile compared to GARGI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check GARGI.BO's competition here
PRAXIS.NS vs LOGICA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, LOGICA.BO has a market cap of 3.8B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while LOGICA.BO trades at ₹213.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas LOGICA.BO's P/E ratio is 27.50. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to LOGICA.BO's ROE of N/A. Regarding short-term risk, PRAXIS.NS is more volatile compared to LOGICA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check LOGICA.BO's competition here
PRAXIS.NS vs PANORAMA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, PANORAMA.BO has a market cap of 3.5B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while PANORAMA.BO trades at ₹44.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas PANORAMA.BO's P/E ratio is 29.84. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to PANORAMA.BO's ROE of +0.20%. Regarding short-term risk, PRAXIS.NS is more volatile compared to PANORAMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check PANORAMA.BO's competition here
PRAXIS.NS vs KDML.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, KDML.BO has a market cap of 3.1B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while KDML.BO trades at ₹132.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas KDML.BO's P/E ratio is 15.77. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to KDML.BO's ROE of +0.16%. Regarding short-term risk, PRAXIS.NS is more volatile compared to KDML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check KDML.BO's competition here
PRAXIS.NS vs COMPEAU.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, COMPEAU.BO has a market cap of 2.4B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while COMPEAU.BO trades at ₹384.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas COMPEAU.BO's P/E ratio is 14.70. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to COMPEAU.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.NS is more volatile compared to COMPEAU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check COMPEAU.BO's competition here
PRAXIS.NS vs AAYUSH.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, AAYUSH.BO has a market cap of 1.6B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while AAYUSH.BO trades at ₹33.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas AAYUSH.BO's P/E ratio is 34.72. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to AAYUSH.BO's ROE of +0.54%. Regarding short-term risk, PRAXIS.NS is more volatile compared to AAYUSH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check AAYUSH.BO's competition here
PRAXIS.NS vs PRAXIS.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, PRAXIS.BO has a market cap of 1.5B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while PRAXIS.BO trades at ₹7.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas PRAXIS.BO's P/E ratio is 4.05. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to PRAXIS.BO's ROE of -1.13%. Regarding short-term risk, PRAXIS.NS is more volatile compared to PRAXIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check PRAXIS.BO's competition here
PRAXIS.NS vs ISFT.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ISFT.BO has a market cap of 1.3B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ISFT.BO trades at ₹81.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ISFT.BO's P/E ratio is 10.67. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ISFT.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ISFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ISFT.BO's competition here
PRAXIS.NS vs ISFT.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ISFT.NS has a market cap of 1.3B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ISFT.NS trades at ₹80.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ISFT.NS's P/E ratio is 10.48. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ISFT.NS's ROE of +0.05%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ISFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ISFT.NS's competition here
PRAXIS.NS vs KEMP.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, KEMP.BO has a market cap of 1B. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while KEMP.BO trades at ₹945.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas KEMP.BO's P/E ratio is -91.75. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to KEMP.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to KEMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check KEMP.BO's competition here
PRAXIS.NS vs DIGIDRIVE.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, DIGIDRIVE.NS has a market cap of 875.6M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while DIGIDRIVE.NS trades at ₹22.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas DIGIDRIVE.NS's P/E ratio is 7.05. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to DIGIDRIVE.NS's ROE of +0.04%. Regarding short-term risk, PRAXIS.NS is more volatile compared to DIGIDRIVE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check DIGIDRIVE.NS's competition here
PRAXIS.NS vs ARCHIES.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ARCHIES.NS has a market cap of 538.1M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ARCHIES.NS trades at ₹15.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ARCHIES.NS's P/E ratio is -51.39. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ARCHIES.NS's ROE of -0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ARCHIES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ARCHIES.NS's competition here
PRAXIS.NS vs ARCHIES.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, ARCHIES.BO has a market cap of 534.1M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while ARCHIES.BO trades at ₹15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas ARCHIES.BO's P/E ratio is -51.00. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to ARCHIES.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to ARCHIES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check ARCHIES.BO's competition here
PRAXIS.NS vs PACE.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, PACE.BO has a market cap of 375.2M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while PACE.BO trades at ₹16.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas PACE.BO's P/E ratio is 9.15. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to PACE.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.NS is more volatile compared to PACE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check PACE.BO's competition here
PRAXIS.NS vs DDIL.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, DDIL.BO has a market cap of 163.4M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while DDIL.BO trades at ₹3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas DDIL.BO's P/E ratio is 5.61. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to DDIL.BO's ROE of +0.13%. Regarding short-term risk, PRAXIS.NS is more volatile compared to DDIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check DDIL.BO's competition here
PRAXIS.NS vs DUKEOFS.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, DUKEOFS.BO has a market cap of 153.9M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while DUKEOFS.BO trades at ₹15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas DUKEOFS.BO's P/E ratio is -6.88. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to DUKEOFS.BO's ROE of -0.12%. Regarding short-term risk, PRAXIS.NS is more volatile compared to DUKEOFS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check DUKEOFS.BO's competition here
PRAXIS.NS vs UHZAVERI.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, UHZAVERI.BO has a market cap of 146.4M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while UHZAVERI.BO trades at ₹15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas UHZAVERI.BO's P/E ratio is 367.25. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to UHZAVERI.BO's ROE of +0.00%. Regarding short-term risk, PRAXIS.NS is more volatile compared to UHZAVERI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check UHZAVERI.BO's competition here
PRAXIS.NS vs DARSHANORNA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, DARSHANORNA.BO has a market cap of 132.9M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while DARSHANORNA.BO trades at ₹2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas DARSHANORNA.BO's P/E ratio is 25.00. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to DARSHANORNA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS.NS is less volatile compared to DARSHANORNA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.NS.Check DARSHANORNA.BO's competition here
PRAXIS.NS vs RAJPUTANA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, RAJPUTANA.BO has a market cap of 106.4M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while RAJPUTANA.BO trades at ₹34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas RAJPUTANA.BO's P/E ratio is 44.29. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to RAJPUTANA.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS.NS is more volatile compared to RAJPUTANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check RAJPUTANA.BO's competition here
PRAXIS.NS vs VEERKRUPA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, VEERKRUPA.BO has a market cap of 83.9M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while VEERKRUPA.BO trades at ₹0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas VEERKRUPA.BO's P/E ratio is 32.00. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to VEERKRUPA.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.NS is more volatile compared to VEERKRUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check VEERKRUPA.BO's competition here
PRAXIS.NS vs HARIAEXPO.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, HARIAEXPO.BO has a market cap of 82.4M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while HARIAEXPO.BO trades at ₹7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas HARIAEXPO.BO's P/E ratio is 54.85. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to HARIAEXPO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.NS is less volatile compared to HARIAEXPO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.NS.Check HARIAEXPO.BO's competition here
PRAXIS.NS vs MHSGRMS.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, MHSGRMS.BO has a market cap of 52.7M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while MHSGRMS.BO trades at ₹6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas MHSGRMS.BO's P/E ratio is 7.88. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to MHSGRMS.BO's ROE of -2.38%. Regarding short-term risk, PRAXIS.NS is more volatile compared to MHSGRMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check MHSGRMS.BO's competition here
PRAXIS.NS vs JSHL.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, JSHL.BO has a market cap of 52.4M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while JSHL.BO trades at ₹8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas JSHL.BO's P/E ratio is -11.88. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to JSHL.BO's ROE of -0.02%. Regarding short-term risk, PRAXIS.NS is more volatile compared to JSHL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.NS.Check JSHL.BO's competition here
PRAXIS.NS vs SPECTRA.BO Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, SPECTRA.BO has a market cap of 41.1M. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while SPECTRA.BO trades at ₹5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas SPECTRA.BO's P/E ratio is -1.67. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to SPECTRA.BO's ROE of +0.07%. Regarding short-term risk, PRAXIS.NS is less volatile compared to SPECTRA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.NS.Check SPECTRA.BO's competition here
PRAXIS.NS vs PRAXIS-RE.NS Comparison February 2026
PRAXIS.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.NS stands at 1.5B. In comparison, PRAXIS-RE.NS has a market cap of 0. Regarding current trading prices, PRAXIS.NS is priced at ₹7.81, while PRAXIS-RE.NS trades at ₹15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.NS currently has a P/E ratio of 4.23, whereas PRAXIS-RE.NS's P/E ratio is N/A. In terms of profitability, PRAXIS.NS's ROE is -1.13%, compared to PRAXIS-RE.NS's ROE of N/A. Regarding short-term risk, PRAXIS.NS is less volatile compared to PRAXIS-RE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.NS.Check PRAXIS-RE.NS's competition here